Article
Intrathecal mesenchymal stem cell therapy in progressive multiple sclerosis: cross-compartment immune profiling in the SMART-MS randomized trial
2026-05-12
Abstract excerpt
<title>Abstract</title> <p>Therapeutic options for progressive multiple sclerosis (MS) remain limited, and the biological mechanisms engaged by intrathecal mesenchymal stem cell (MSC) therapy are incompletely understood. MSCs are proposed to exert immunomodulatory and trophic effects, yet most studies rely on targeted biomarkers and lack systems-level analysis across immune compartments. Here, we applied an integ...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 75da16c6-89ff-530e-b370-05b190dddfec
- DOI
- 10.21203/rs.3.rs-9629755/v1
